Since its inception, The Jackson Laboratory has led the discovery of causes, treatments and cures for some of humankind's most devastating genetic diseases. Today, we are speeding the path of discovery from the laboratory bench to clinical care. We are combining the skills and knowledge of our scientists with our institutional strengths in disease modeling and bioinformatics, connecting genetics to genomics, and using our unparalleled knowledge of mouse models of disease to understand the human condition.
JAX research programs are leading efforts to improve human health worldwide.
Addiction is a chronic illness, with genetic, environmental and social aspects. JAX researchers are at the forefront of understanding the genetic factors involved in individuals’ vulnerability to addiction.
JAX researchers are using genomic technologies and specialized mouse models to decipher the changes that occur as a consequence of aging in order to extend our health span, delay age-related health issues, repair damaged organs and improve our quality of life.
Using genomic technologies and specialized mouse models to develop preventative therapies, JAX scientists aim to stop Alzheimer’s before it starts.
Driven by the desire to eradicate cancer, we are leading the future of cancer treatments by combining computational expertise with our unparalleled knowledge of mouse genetics.
JAX researchers investigate the processes that lead to failure to produce insulin in type 1 diabetes and loss of insulin production in type 2 diabetes.
JAX researchers are exploring the effect on health and disease of the microorganisms that outnumber human cells 10 to 1.
About 80 percent of rare diseases are genetic in origin, about half affect children, many are fatal, and very few have cures.
We identify the genetic and molecular bases of disease and marshal our strengths in genomics and disease modeling to discover individualized treatments and cures so that medicine is more precise, predictable and personal.
For the rarest of rare genetic conditions, a one-of-a-kind mouse could light a path to new treatments.
JAX Professor Robert Burgess and collaborators are developing personalized gene therapy for a Texas child suffering from a neuromuscular disease.
By harnessing the most advanced data-mining tools, JAX Professor Carol Bult is leading the hunt for suspect genes that contribute to a common, deadly birth defect.